Masimo (Masimo) Cash, Cash Equivalents, Marketable Securities : $163 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Masimo Cash, Cash Equivalents, Marketable Securities?

Masimo's quarterly cash, cash equivalents, marketable securities declined from Jun. 2023 ($150.70 Mil) to Sep. 2023 ($124.40 Mil) but then increased from Sep. 2023 ($124.40 Mil) to Dec. 2023 ($163.00 Mil).

Masimo's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($745.30 Mil) to Dec. 2022 ($202.90 Mil) and declined from Dec. 2022 ($202.90 Mil) to Dec. 2023 ($163.00 Mil).

Masimo Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Masimo's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Masimo Cash, Cash Equivalents, Marketable Securities Chart

Masimo Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

687.69

641.45

745.30

202.90

163.00

Masimo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															202.90	174.10	150.70	124.40	163.00

Masimo Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Masimo (NAS:MASI) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Masimo Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Masimo's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Masimo (Masimo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (NAS:MASI) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

MASI:Mexico 3M4:Germany 3M4:Germany

Address

52 Discovery, Irvine, CA, USA, 92618

Website

https://www.masimo.com

Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Executives

Rolf A Classon	director	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Politan Capital Management Gp Llc	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Partners Gp Llc	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Quentin Koffey	other: Director by deputization	POLITAN CAPITAL MANAGEMENT LP, 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Management Lp	other: Director by deputization	106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Michelle Brennan	director	1855 S. GRANT STREET, SAN MATEO CA 94402
Joe E Kiani	director, officer: CEO and Chairman of the Board	4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Hataishi	officer: SVP, Chief Accounting Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Blair Tripodi	officer: COO, Consumer Division	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Kevin P Duffy	officer: President, Consumer	1 VIPER WAY, VISTA CA 92081
Adam Mikkelson	director	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Tao Levy	officer: EVP BUS DEV	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Micah W Young	officer: EVP & Chief Financial Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Thomas Samuel Mcclenahan	officer: EVP & GENERAL COUNSEL	40 PARKER, IRVINE CA 92618
Craig B Reynolds	director	1046 MIDDLEBROOK WAY, KENESAW GA 30144